CPHI & PMEC China 2026
06/2026 – 06/2026
会社概要
- 正式社名: Sichuan Qingmu Pharmaceutical Co., Ltd
- 登録国: China
- 住所: 55, South Shunjiang Avenue,, East Economic Development Zone, Dongpo District, Meishan
- 従業員数: 250 - 499
説明:
Established in 2011, Sichuan Qingmu Pharmaceuticals Co., Ltd. is mainly engaged in manufacturing APIs and advanced intermediates, with CMO/CDMO services also part of its business scope. Qingmu has obtained GMP certificates for 10 APIs, 3 J-MFs, 1 US DMF, 2 US VMFs and 1 CEP, and has passed USFDA site inspection.
事業活動
先発品原薬
製造業者受託製造業者(CMO)
販売市場
- East Asia: China, Democratic People's Republic of Korea, Mongolia, Republic of Korea, Japan, Taiwan
- South Asia: Bangladesh, Bhutan, India, Maldives, Nepal, Pakistan, Sri Lanka, Afghanistan, Iran
- Mainland Southeast Asia: Cambodia, Lao People's Democratic Republic, Myanmar, Thailand, Viet Nam, Brunei Darussalam, Indonesia, Malaysia, Philippines, Timor-Leste, Singapore
- Melanesia: Papua New Guinea
- Western Asia: United Arab Emirates, Armenia, Azerbaijan
当社の製品・サービス
証明
評価
(0)
(0)
(0)
(0)
(0)
コメント
フィルター:
並べ替え:
コメントはありません。
評価とコメントを残す